• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Keloid Treatment Market

    ID: MRFR/Pharma/5340-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    Keloid Treatment Market Research Report Information By Product (Elastic Wraps, Ointment), by Treatment (Radiation Therapy, Cry Therapy, Surgical Treatment, Laser Treatment, Laser Treatment, Interferon), by End-User (Hospitals and Others), Regions - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Keloid Treatment Market Research Report - Global Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Keloid Treatment Market Summary

    The Global Keloid Treatment Market is projected to grow from 1.73 USD Billion in 2024 to 1.9 USD Billion by 2035.

    Key Market Trends & Highlights

    Keloid Treatment Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 0.86% from 2025 to 2035.
    • By the year 2035, the market valuation is anticipated to reach 1.9 USD Billion, reflecting steady growth.
    • In 2024, the market is valued at 1.73 USD Billion, indicating a solid foundation for future expansion.
    • Growing adoption of advanced treatment modalities due to increasing awareness of keloid management is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.73 (USD Billion)
    2035 Market Size 1.9 (USD Billion)
    CAGR (2025-2035) 0.86%

    Major Players

    Novartis, AGRXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation, Avita Medical Limited, Sensus Healthcare, Perrigo Company plc

    Keloid Treatment Market Drivers

    Market Growth Projections

    The Global Keloid Treatment Market Industry is projected to experience steady growth, with estimates indicating a market size of 1.73 USD Billion in 2024 and a potential increase to 1.9 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 0.86% from 2025 to 2035. Such projections highlight the ongoing demand for keloid treatments and the industry's responsiveness to emerging trends and technologies. The market's expansion reflects broader healthcare trends, including a focus on personalized medicine and improved patient care.

    Rising Cosmetic Procedures

    The rise in cosmetic procedures is another driver for the Global Keloid Treatment Market Industry. As more individuals undergo surgeries for aesthetic enhancements, the likelihood of keloid formation increases. This trend is particularly pronounced in regions where cosmetic surgery is gaining popularity. Patients seeking to minimize the appearance of keloids post-surgery are driving demand for effective treatment solutions. The market's growth is expected to be sustained as the beauty industry continues to expand, with keloid treatments becoming an integral part of post-operative care.

    Rising Prevalence of Keloids

    The Global Keloid Treatment Market Industry is experiencing growth due to the rising prevalence of keloids, which are often associated with surgical scars, acne, and trauma. As awareness increases regarding the condition, more individuals seek treatment options. In 2024, the market is projected to reach 1.73 USD Billion, reflecting a growing demand for effective therapies. This trend is particularly evident in regions with high rates of skin injuries, such as urban areas where surgical procedures are common. The increasing incidence of keloids is likely to drive innovation in treatment modalities, further expanding the market.

    Growing Awareness and Education

    The Global Keloid Treatment Market Industry benefits from increasing awareness and education about keloids among both healthcare professionals and patients. Educational campaigns and resources provided by dermatological associations are helping to demystify keloids, leading to earlier diagnosis and treatment. This heightened awareness is crucial, as it encourages individuals to seek medical advice sooner, thereby increasing treatment uptake. As more patients become informed about their options, the market is likely to see a steady rise in demand for keloid treatments, contributing to a projected CAGR of 0.86% from 2025 to 2035.

    Increased Research and Development

    Increased investment in research and development is propelling the Global Keloid Treatment Market Industry forward. Pharmaceutical companies and research institutions are focusing on understanding the underlying mechanisms of keloid formation, which may lead to the discovery of novel therapeutic agents. This emphasis on R&D is likely to yield new treatment options that are more effective and tailored to individual patient needs. As the market evolves, the introduction of innovative therapies could significantly alter the treatment landscape, enhancing patient satisfaction and outcomes.

    Advancements in Treatment Technologies

    Innovations in treatment technologies are significantly influencing the Global Keloid Treatment Market Industry. New methods, such as laser therapy, cryotherapy, and intralesional injections, are being developed and refined, offering patients more effective options. These advancements not only enhance treatment efficacy but also reduce recovery times and side effects. As a result, healthcare providers are increasingly adopting these technologies, contributing to market growth. The anticipated increase in market size to 1.9 USD Billion by 2035 underscores the potential of these advancements to reshape treatment paradigms and improve patient outcomes.

    Market Segment Insights

    Keloid Treatment Product Type Insights

    Based on product type the market is segmented into elastic wraps, spray, ointment, creams, oils, topical gels & gel sheets.

    Keloid Treatment Insights

    Based on treatment market for keloid has been segmented into ligature, radiation therapy, cry therapy, surgical treatment, laser treatment, steroid injections, corticosteroid injections (intralesional steroids), silicone gel or sheeting, occlusive dressing, compression therapy, and interferon. Corticosteroid injections treatment segments lead the keloid treatment market as this treatment is used in combination with other therapies. Intralesional steroids injection is considered to be the second largest segment of treatment type that drives market.

    Keloid Treatment End-User Insights

    On the basis of end-users, the keloid treatment market is segmented into dermatology clinics, hospitals, ambulatory surgical centers. Hospital is expected to hold the largest share in the segment market of end-users as most doctors prefer radiation therapy which has reported safe and effective use of radiation to treat keloid.

    Get more detailed insights about Keloid Treatment Market Research Report - Global Forecast till 2032

    Key Companies in the Keloid Treatment Market market include

    Industry Developments

    POETYK PSO-2, the second pivotal Phase III clinical trial assessing deucravacitinib, a new, selective tyrosine kinase 2 inhibitor for the treatment of patients with moderate to severe plaque psoriasis, was published in February 2021 by Bristol Myers Squibb Company.

    POETYK PSO-2 looked at deucravacitinib 6 mg once a day and found that it met both co-primary objectives, with considerably more patients reaching Psoriasis Area and Severity Index (PASI 75). JUBLIA (efinaconazole) topical solution for the treatment of onychomycosis was approved by the US Food and Drug Administration (FDA) in April 2020 for Bausch Health Companies Inc. and its dermatology business Ortho Dermatologics in Keloid Treatment Market

    Intended Audience

      • Manufacturers and Suppliers
      • Dermatology Hospitals and Clinics
      • Dermatology laboratories and associations
      • Research and development centers

     

    Future Outlook

    Keloid Treatment Market Future Outlook

    The Global Keloid Treatment Market is projected to grow at a 0.86% CAGR from 2024 to 2035, driven by advancements in treatment technologies and increasing awareness of skin conditions.

    New opportunities lie in:

    • Develop targeted therapies utilizing gene editing techniques for keloid prevention.
    • Expand telemedicine platforms for remote consultations and follow-ups in keloid treatment.
    • Invest in educational campaigns to raise awareness about keloid management options.

    By 2035, the Keloid Treatment Market is expected to stabilize, reflecting gradual growth and evolving treatment paradigms.

    Market Segmentation

    Keloid Treatment Region Outlook

    • Americas
    • North America
    • US
    • Canada
    • South America
    • Europe
    • Western Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Western Europe
    • Eastern Europe
    • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Republic of Korea
    • Rest of Asia Pacific
    • Middle East & Africa
    • Middle East
    • Africa
    • Manufacturers and Suppliers
    • Dermatology Hospitals and Clinics
    • Dermatology laboratories and associations
    • Research and development centers

    Keloid Treatment End User Outlook

    • Dermatology clinics
    • Hospitals
    • Ambulatory surgical centers
    • Others

    Keloid Treatment Treatment Outlook

    • Ligature
    • Radiation Therapy
    • Cry Therapy
    • Surgical Treatment
    • Laser Treatment
    • Steroid Injections
    • Corticosteroid injections (intralesional steroids)
    • Silicone gel or sheeting
    • Interferon

     Keloid Treatment Product Type Outlook

    • Elastic Wraps
    • Sprays
    • Ointment
    • Creams
    • Oils
    • Topical Gels & Gel Sheets

    Report Scope

    Report Attribute/Metric Details
      Market Size   USD 1.72 Billion
      CAGR   3.3%
      Base Year   2021
      Forecast Period   2023-2032
      Historical Data   2020
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   By Product, Treatment, End-User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Novartis AG, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation, Avita Medical Limited, Sensus Healthcare, Perrigo Company plc.
      Key Market Opportunities   Increasing research & development investments by industry players
      Key Market Drivers ·  Rapid rise in the technological scenario behind skin care products ·  Treatment type - Intralesional steroids injection

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the valuation of the global keloid market?

    The global keloid market is expected to reach a valuation of USD 1.72 billion by 2032.

    What is the CAGR of the market?

    The market is expected to exhibit a strong 3.3% CAGR over the forecast period from 2023-2032.

    What is the leading driver for the market?

    The rapid rise in the technological scenario behind skin care products is the major driver for the global keloid treatment market.

    What is the leading regional market?

    North America is the dominant regional market for keloid treatment.

    What are the key players in the market?

    Leading players in the keloid treatment market include Valeant, RXi Pharmaceuticals, Novartis, and Pacific World Corporation, among others.

    Keloid Treatment Market Research Report - Global Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials